Amedisys Q4 2023 Adj EPS $0.940 Misses $1.030 Estimate, Sales $570.800M Beat $567.713M Estimate
Author: Benzinga Newsdesk | March 05, 2024 05:19pm
Amedisys (NASDAQ:
AMED) reported quarterly earnings of $0.940 per share which missed the analyst consensus estimate of $1.030 by 8.74 percent. The company reported quarterly sales of $570.800 million which beat the analyst consensus estimate of $567.713 million by 0.54 percent. This is a 1.55 percent increase over sales of $562.064 million the same period last year.
Posted In: AMED